Hannah Fry is VP, Controller of Protara Therapeutics, Inc.. Currently has a direct ownership of 29,836 shares of TARA, which is worth approximately $61,760. The most recent transaction as insider was on Jan 19, 2024, when has been sold 904 shares (Common Stock) at a price of $1.91 per share, resulting in proceeds of $1,726. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.8K
0% 3M change
9.97% 12M change
Total Value Held $61,760

Hannah Fry Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 19 2024
SELL
Payment of exercise price or tax liability
$1,726 $1.91 p/Share
904 Reduced 2.94%
29,836 Common Stock
Jan 19 2024
BUY
Grant, award, or other acquisition
-
8,000 Added 20.65%
30,740 Common Stock
Jan 03 2024
SELL
Payment of exercise price or tax liability
$703 $2.17 p/Share
324 Reduced 1.4%
22,740 Common Stock
Jul 17 2023
SELL
Payment of exercise price or tax liability
$25,792 $2.56 p/Share
10,075 Reduced 30.4%
23,064 Common Stock
Jan 19 2023
BUY
Grant, award, or other acquisition
-
5,900 Added 15.11%
33,139 Common Stock
Jan 03 2023
SELL
Payment of exercise price or tax liability
$1,010 $2.8 p/Share
361 Reduced 1.31%
27,239 Common Stock
Jul 16 2022
BUY
Grant, award, or other acquisition
-
25,000 Added 47.53%
27,600 Common Stock
HF

Hannah Fry

VP, Controller
New York, NY

Track Institutional and Insider Activities on TARA

Follow Protara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARA shares.

Notify only if

Insider Trading

Get notified when an Protara Therapeutics, Inc. insider buys or sells TARA shares.

Notify only if

News

Receive news related to Protara Therapeutics, Inc.

Track Activities on TARA